Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Gray

Showing results (161-170 of 163) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 163 results.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognosesH E Campbell, D Epstein, D Bloomfield, et al.
Current Biology : CB|March 13, 1999
Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITRA L Gurney, S A Marsters, R M Huang, et al.
Leukemia|July 3, 2010
Anti-CD22-MCC-DM1: an antibody-drug conjugate with a stable linker for the treatment of non-Hodgkin's lymphomaA G Polson, M Williams, A M Gray, et al.
Pageof 17

Showing results (161-170 of 163) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 163 results.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognosesH E Campbell, D Epstein, D Bloomfield, et al.
Current Biology : CB|March 13, 1999
Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITRA L Gurney, S A Marsters, R M Huang, et al.
Leukemia|July 3, 2010
Anti-CD22-MCC-DM1: an antibody-drug conjugate with a stable linker for the treatment of non-Hodgkin's lymphomaA G Polson, M Williams, A M Gray, et al.
Pageof 17